Does missing medication acutely change seizure risk? A prospective study
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Importance
Medication adherence is widely emphasized in epilepsy management, with a belief that missing even single doses can trigger seizures. However, scientific evidence supporting this specific claim is limited, particularly regarding the impact of occasional missed doses rather than prolonged non-adherence.
Objective
To determine whether missing individual doses of anti-seizure medications (ASMs) increases short-term seizure risk in people with drug-resistant epilepsy.
Design
Prospective cohort study conducted over 10 months for each participant, with data collected from March 2022 through January 2023. Analysis was performed in February 2023.
Setting
Community-based study with participants recruited via emails and online services.
Participants
Adults with drug-resistant epilepsy experiencing 3 or more seizures per month, or adult caregivers of pediatric patients meeting these criteria. Participants used mobile applications to document both seizure occurrences and medication adherence.
Exposure
Daily documentation of ASM doses, with missed doses categorized as 0 (no missed doses), 1 (one missed administration period), or 2 (two missed administration periods) per day.
Main Outcomes and Measures
27 participants (median age 29) were followed. The relationship between seizure occurrence and missed ASM doses was assessed using mixed-effects logistic regression models, controlling for baseline seizure risk using a 90-day moving average (the “Napkin method”). Various time windows for missed doses and analyses accounting for medication half-lives were examined.
Results
The Napkin method for seizure risk was significantly related to seizure occurrence (p<0.001). However, missed ASM doses the day prior showed no significant relationship with seizure occurrence (p = 0.68). This lack of association persisted when examining longer time windows of missed doses and when accounting for medication half-lives. Sensitivity analyses demonstrated that the statistical approach could detect even small effects (5% increased seizure probability) of missed medication, confirming that the negative finding was less likely due to methodology.
Conclusions and Relevance
While long-term medication non-adherence remains an important concern in epilepsy management, this study found no evidence that occasionally missing ASM doses significantly increases short-term seizure risk. These findings suggest that clinicians might reasonably reassure patients that infrequent missed doses may not dramatically impact immediate seizure likelihood, though consistent medication adherence should still be encouraged.
KEY POINTS
Question
Does missing individual doses of anti-seizure medications significantly increase short-term seizure risk in people with drug-resistant epilepsy?
Findings
In this 10-month prospective cohort study, the 90-day moving average of seizure frequency was significantly associated with seizure occurrence (p < 0.001), but missed anti-seizure medication doses showed no significant association with seizure occurrence (p = 0.68), even when accounting for medication half-lives or examining different time windows.
Meaning
While long-term medication adherence remains important in epilepsy management, occasionally missing doses may not significantly impact immediate seizure likelihood, which may help reduce unnecessary anxiety in patients who miss infrequent doses.
